{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:43:56Z","timestamp":1792100636179,"version":"4.4.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Asia"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jacasi.2026.08.031","type":"journal-article","created":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:44:12Z","timestamp":1792097052000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["LDL-Cholesterol Targets Post-ACS and CCS"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6690-6874","authenticated-orcid":false,"given":"Maciej","family":"Banach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0345-3876","authenticated-orcid":false,"given":"Yashendra","family":"Sethi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9378-6505","authenticated-orcid":false,"given":"Kunal","family":"Mahajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacasi.2026.08.031_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacasi.2026.07.004","article-title":"Cardiovascular outcomes in response to achieved LDL-C levels after PCI in ACS and CCS","author":"Kataoka","year":"2026","journal-title":"JACC Asia"},{"issue":"12","key":"10.1016\/j.jacasi.2026.08.031_bib2","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1007\/s40265-024-02105-5","volume":"84","author":"Banach","year":"2024","journal-title":"Drugs"},{"issue":"9753","key":"10.1016\/j.jacasi.2026.08.031_bib3","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","author":"Baigent","year":"2010","journal-title":"Lancet"},{"issue":"39","key":"10.1016\/j.jacasi.2026.08.031_bib4","doi-asserted-by":"crossref","first-page":"4204","DOI":"10.1093\/eurheartj\/ehae576","article-title":"Intensive early and sustained lowering of non-high-density lipoprotein cholesterol after myocardial infarction and prognosis: the SWEDEHEART registry","volume":"45","author":"Schubert","year":"2024","journal-title":"Eur Heart J"},{"issue":"15","key":"10.1016\/j.jacasi.2026.08.031_bib5","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/j.jacc.2025.02.007","article-title":"Early ezetimibe initiation after myocardial infarction protects against later cardiovascular outcomes in the SWEDEHEART registry","volume":"85","author":"Leosdottir","year":"2025","journal-title":"J Am Coll Cardiol"},{"issue":"18","key":"10.1016\/j.jacasi.2026.08.031_bib6","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.030414","article-title":"Intensive statin therapy vs upfront combination therapy of statin and ezetimibe in patients with acute coronary syndrome: a propensity score matching analysis based on the PL-ACS data","volume":"12","author":"Lewek","year":"2023","journal-title":"J Am Heart Assoc"},{"issue":"12","key":"10.1016\/j.jacasi.2026.08.031_bib7","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/j.mayocp.2025.01.018","volume":"100","author":"Banach","year":"2025","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"10.1016\/j.jacasi.2026.08.031_bib8","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1093\/cvr\/cvaf045","article-title":"Upfront lipid-lowering combination therapy in high cardiovascular risk patients: a route to effective atherosclerotic cardiovascular disease prevention","volume":"121","author":"Banach","year":"2025","journal-title":"Cardiovasc Res"},{"issue":"5","key":"10.1016\/j.jacasi.2026.08.031_bib9","doi-asserted-by":"crossref","first-page":"e867","DOI":"10.1016\/j.jacl.2024.06.001","article-title":"Rapid achievement of low-density lipoprotein cholesterol goals within 1 month after acute coronary syndrome during combination therapy with rosuvastatin, ezetimibe and bempedoic acid: initial experience from the LAI-REACT study","volume":"18","author":"Mahajan","year":"2024","journal-title":"J Clin Lipidol"},{"issue":"4","key":"10.1016\/j.jacasi.2026.08.031_bib10","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1161\/CIRCIMAGING.112.973701","article-title":"Nonculprit plaques in patients with acute coronary syndromes have more vulnerable features compared with those with non-acute coronary syndromes: a 3-vessel optical coherence tomography study","volume":"5","author":"Kato","year":"2012","journal-title":"Circ Cardiovasc Imaging"},{"issue":"18","key":"10.1016\/j.jacasi.2026.08.031_bib11","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1001\/jama.2022.5218","article-title":"Effect of alirocumab added to high-intensity statin therapy on coronary atherosclerosis in patients with acute myocardial infarction: the PACMAN-AMI randomized clinical trial","volume":"327","author":"R\u00e4ber","year":"2022","journal-title":"JAMA"},{"issue":"34","key":"10.1016\/j.jacasi.2026.08.031_bib12","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1093\/eurheartj\/ehac015","article-title":"Prevalence of statin intolerance: a meta-analysis","volume":"43","author":"Byty\u00e7i","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacasi.2026.08.031_bib13","article-title":"Treatment gaps in the implementation of LDL cholesterol control among high- and very high-risk patients in Europe between 2020 and 2021: the multinational observational SANTORINI study","volume":"29","author":"Ray","year":"2023","journal-title":"Lancet Reg Health Eur"},{"issue":"4","key":"10.1016\/j.jacasi.2026.08.031_bib14","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.amjmed.2015.10.024","article-title":"2013 cholesterol guidelines revisited: percent LDL cholesterol reduction or attained LDL cholesterol level or both for prognosis?","volume":"129","author":"Bangalore","year":"2016","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.jacasi.2026.08.031_bib15","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jacl.2024.10.010","article-title":"Clinical impact of \u226550% reduction of low density lipoprotein cholesterol following lipid lowering therapy on cardiovascular outcomes in patients with acute coronary syndrome","volume":"19","author":"Fujioka","year":"2025","journal-title":"J Clin Lipidol"},{"issue":"5","key":"10.1016\/j.jacasi.2026.08.031_bib16","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1093\/ehjci\/jeag057","article-title":"Achieved LDL-C levels <55 mg\/dL and cardiac events in patients and lesions harbouring lipid-rich plaque phenotypes","volume":"27","author":"Kataoka","year":"2026","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"1","key":"10.1016\/j.jacasi.2026.08.031_bib17","doi-asserted-by":"crossref","first-page":"41","DOI":"10.5334\/gh.1559","article-title":"Global lipid guidelines: more aligned than they appear","volume":"21","author":"Sethi","year":"2026","journal-title":"Glob Heart"},{"issue":"42","key":"10.1016\/j.jacasi.2026.08.031_bib18","doi-asserted-by":"crossref","first-page":"4359","DOI":"10.1093\/eurheartj\/ehaf190","article-title":"2025 focused update of the 2019 ESC\/EAS guidelines for the management of dyslipidaemias","volume":"46","author":"Mach","year":"2025","journal-title":"Eur Heart J"},{"issue":"11","key":"10.1016\/j.jacasi.2026.08.031_bib19","doi-asserted-by":"crossref","first-page":"e888","DOI":"10.4244\/EIJ-D-22-00735","article-title":"Effects of routine early treatment with PCSK9 inhibitors in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a randomised, double-blind, sham-controlled trial","volume":"18","author":"Mehta","year":"2022","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jacasi.2026.08.031_bib20","article-title":"Global burden of elevated LDL-C: findings from the global burden of disease study 2023","volume":"29","author":"Razo","year":"2026","journal-title":"JAMA"}],"container-title":["JACC: Asia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772374726007933?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772374726007933?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:44:14Z","timestamp":1792097054000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772374726007933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":20,"alternative-id":["S2772374726007933"],"URL":"https:\/\/doi.org\/10.1016\/j.jacasi.2026.08.031","relation":{},"ISSN":["2772-3747"],"issn-type":[{"value":"2772-3747","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"LDL-Cholesterol Targets Post-ACS and CCS","name":"articletitle","label":"Article Title"},{"value":"JACC: Asia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacasi.2026.08.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jacasi.2026.07.004","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}